CareRx Corporation
TSX:CRRX.TOMedical - Care Facilities
+$0.02 today
- Market cap
- $203.06M
- Beta
- 0.62
- P/E (TTM)
- 7.4
- EPS (TTM)
- $0.43
- Dividend yield
- 1.88%
Volume 0.01M
Average 0.04M
Returns on capital
CareRx Corporation management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
23.9%
avg -3.1%
ROIC
5.9%
avg -2.0%
ROA
10.3%
avg -9.4%
Analysis
ROE is currently the strongest return metric at 23.9% versus its period average of -3.1%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Puneet Khanna | Chief Executive Officer, President & Director | CAD 817.13K | — | — | — |
Suzanne Brand | Chief Financial Officer | CAD 438.65K | — | — | — |
Adrianne Sullivan Campeau | Chief Employee & Customer Experience Officer | CAD 401.73K | — | — | — |
Travis Featherstone | Chief Clinical Officer | CAD 360.45K | — | — | — |
Alpinder Grewal | Chief Operating Officer | CAD 354.99K | — | — | — |
Davide Pernarella | Vice President of Business Planning & Analysis | — | — | — | — |
Erwin Van Hout | Senior Vice President of Information Technology | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
No open-market purchases or sales in the last 12 months.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | -20.0% (3yr)3 analysts |
| Revenue | N/A | N/A | -1.0% | +4.2% (3yr)4 analysts |
| Net Income | N/A | N/A | N/A | -20.5% (3yr)4 analysts |
| EBIT | N/A | N/A | N/A | +27.8% (3yr)4 analysts |
Analysis
Recent growth has been strongest in Revenue at -1.0% over three years. Forward estimates point to EBIT at +27.8% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does CareRx Corporation compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CRRX.TO's management, answered from reported figures.
Who manages CRRX.TO?
CareRx Corporation (CRRX.TO) lists 7 active executives. The top listed executive is Alpinder Grewal, Chief Operating Officer.
Continue the stock analysis
Jump to another research area for this company.